Cancer Drugs Fund: Life-extending drugs to be denied to NHS patients in England as fund overspends, The Independent
€ 36.99 · 4.8 (708) · In Magazzino
i Editor's Letter: Cancer drugs to be denied to NHS patients in
UK newspaper reporting of the NHS cancer drugs fund, 2010 to 2015
1000s of NHS cancer patients to be denied treatment due to funding
PDF) Do patient access schemes for high-cost cancer drugs deliver
Overspend means the Cancer Drugs Fund 'no longer sustainable' – NAO
Cancer Drugs Fund to be restricted - says NHS - BBC News
England, International Health Care System Profiles
PDF) Scoping Review of International Experience of a Dedicated
cancer drugs fund
UK newspaper reporting of the NHS cancer drugs fund, 2010 to 2015
Making outcome-based payment a reality in the NHS
Performance Tracker 2023: Hospitals
The merry-go-round of approval, pricing and reimbursement of drugs
Health economics: the cancer drugs cost conundrum - Cancer
